Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kubra Nur Toplutas"'
Autor:
Sait Sager, Fatih Gulsen, Rahmi Oklu, Nami Yeyin, Fatih Beytur, Seckin Bilgic, Elife Akgun, Omer Aras, Feifei An, Haluk Sayman, Kubra Nur Toplutas
Publikováno v:
Journal of Vascular and Interventional Radiology. 33:342-345
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1260ed7eac51aee4f3e23b4d8a7dde70
https://doi.org/10.1016/j.jvir.2021.10.016
https://doi.org/10.1016/j.jvir.2021.10.016
Autor:
Fatih Beytur, Haluk Sayman, Rahmi Oklu, Sait Sager, Omer Aras, Nami Yeyin, Kubra Nur Toplutas, Fatih Gulsen, Seckin Bilgic, Elife Akgun
Purpose177Lu-PSMA is a promising therapy for patients with metastatic castration resistant prostate cancer patients (mCRPC). To our knowledge, no study has compared the pharmacokinetic profiles of 177Lu-PSMA therapy delivered intra-arterially. We aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96a6865f14d192e849e05a2ecb3f840a
https://doi.org/10.21203/rs.3.rs-173258/v1
https://doi.org/10.21203/rs.3.rs-173258/v1
Autor:
Fuat Demirelli, Nilay Sengul Samanci, Sahin Bedir, Kubra Nur Toplutas, Zehra Durak Sahin, Umut Yilmaz, Hilal Aki, Nurgul Ozgur Yurttas, Ahmet Emre Eskazan, Kerem Oruc, Emir Celik
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(8)
Introduction Immune checkpoint inhibitors have demonstrated the benefit for many cancer types, melanoma, non-small cell lung cancer, urothelial cancer, renal cell cancer, etc. Especially in advanced non-small cell lung cancer, significant improvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4fd4bf9bbca8b0d3d79dbd5084d0158
https://pubmed.ncbi.nlm.nih.gov/32299317
https://pubmed.ncbi.nlm.nih.gov/32299317
Autor:
Buket Caliskaner Ozturk, Ersan Atahan, Aysegul Gencer, Deniz Ongel Harbiyeli, Emine Karabul, Nejdiye Mazıcan, Kubra Nur Toplutas, Hazal Cansu Acar, Sait Sager, Bilun Gemicioglu, Sermin Borekci
Publikováno v:
Annals of Nuclear Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::264c29dcf3753c5c51dee8062b06422e
http://europepmc.org/articles/PMC8317479
http://europepmc.org/articles/PMC8317479